In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...

The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of ...

Rapper Fat Joe recently shared how he’s been using the Type 2 diabetes medication Ozempic to maintain his 200-pound weight ...

The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...

One of the biggest changes takes effect in 2025. Part D drug plans must cap out-of-pocket spending on covered drugs at $2,000 ...

New weight-loss jabs could help boost the economy in Britain by getting people “back into work”, the Prime Minister has said. Sir Keir Starmer said that the anti-obesity medication could also help ...

A study by Health Innovation Manchester and Lilly will examine the “real-world effectiveness” of anti-obesity treatment Mounjaro, also known as tirzepatide, on weight loss, diabetes prevention, the ...

Albert Bourla, who four years ago led Pfizer through its scientific and financial triumph during the COVID-19 pandemic, is ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

Thousands of Americans are diagnosed with Type 1 diabetes every year, according to the American Diabetes Association. But a new medication now available worldwide has the potential to drive that ...

For the first time in more than two decades, a completely new form of antipsychotic medication ... insurance providers will cover such a drug, given the abundance of cheaper alternatives. The FDA has ...